Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Glenn Dubin currently holds 22,075 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glenn Dubin has been a net seller of CCCC stock. They have purchased $0 and sold $14.0M worth of shares.
Glenn Dubin's most recent insider trade was on Apr 1, 2024, when they sold 1,358 shares at $8.10 per share.
Glenn Dubin serves as Executive at C4 Therapeutics, Inc. (CCCC). They have executed 21 insider transactions totaling $14.0M over their tenure at the company.
Glenn Dubin holds the position of Executive at C4 Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Glenn Dubin has shown a selling trading pattern, with $0 in total purchases and $14.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Glenn Dubin was on Dec 31, 2011, when they sold $6.3M worth of NONE shares. This transaction involved 63,585 shares at $99.63 per share.
Glenn Dubin currently owns 22,075 shares of C4 Therapeutics, Inc. (CCCC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Glenn Dubin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Glenn Dubin has 21 Form 4 filings on record as an insider at C4 Therapeutics, Inc..
Set alerts for Glenn Dubin and 40,000+ other insiders.